Pharmatech Associates Launches International Contracting and Services Company in Qatar

Pharmatech Associates has introduced Pharmatech Associates International Contracting and Services, LLC (PAICS), a new company with headquarters in Doha, Qatar at the ISPE annual meeting today.  PAICS provides a global, single-source platform for clients and investors from which next-generation pharmaceutical facilities can be designed, constructed, and operated, anywhere in the world.

“PAICS imagines a world where pharmaceutical innovators know no bounds. Neither the high costs of construction nor lack of local manufacturing expertise should prohibit opportunities for growth and expansion,” said Bikash Chatterjee, President and Chief Science Officer, Pharmatech Associates, Inc. “We are extending the Pharmatech brand—associated with the highest quality standards—to create new, local facilities that integrate product and process development, compliance, regulatory affairs and validation from drug design to commercialization.”

PAICS, with its strategic alliance with FAL Group of Doha, Qatar, will provide drug and product development solutions, including generic drug products, biosimilars, and NCEs, integrating facility design and construction; manufacturing equipment selection; Quality Management System (QMS) integration; management staffing and training; facilities commissioning and qualification; facilities, drug, and product regulatory registration; and commercial operations management.

“From our decades of industry experience serving clients, we created PAICS as a single-source solution to producing capital-efficient life science facilities for product development, manufacturing, and quality control assurance with fully integrated, optimized QMS,” said Warren G. Baker, CEO and Chairman of Pharmatech Associates, Inc. “PAICS heralds an era of local design and management of new facilities purpose-built to comply with all regulatory requirements to meet the highest standards of the FDA, EMA and WHO.”